<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00840905</url>
  </required_header>
  <id_info>
    <org_study_id>Merck P0806</org_study_id>
    <nct_id>NCT00840905</nct_id>
  </id_info>
  <brief_title>A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil</brief_title>
  <official_title>A Pilot Observational Study to Determine the Prevalence of HPV Serology in HIV Seropositive Women From Subsaharan Africa and Brasil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynthia S Firnhaber</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Witwatersrand, South Africa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to determine what Human Papillomavirus HIV seropositive women in Botswana,
      South Africa and Brasil have been exposed to during their life. The Human Papillomavirus
      causes cervical cancer. Different types are more likely to lead to cancer than other types. A
      vaccine has been made to fight infection against HPV 16 and 18 which has been shown to cause
      cervical cancer in America and Europe. What HPV type cause cancer in other countries is not
      as well studied.

      Hypothesis HPV serology will demonstrate that exposure to each HPV type in Gardisil
      (6,11,16,18) will be &lt;50% in HIV seropositive women in resource limited countries.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Plasma from HIV seropositive women will be taken and sent to MERCK in the USA to evaluate
      what the antibody titers of HPV 6,11,16 and 18. .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the seroprevalence of HPV types 6,11,16,18 in HIV serOpositive women for Botswana, South Africa and Brazil</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">487</enrollment>
  <condition>HIV</condition>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>HIV seropositive women from an HIV Antiretroviral therapy clinic in Johannesburg South Africa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>A cohort of HIV seropositive women from Gabarone Botswana</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>A cohort of HIV seropositive women from Rio De Janeiro Brasil</description>
  </arm_group>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood /plasma specimen 10cc
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV seropositive women from South Africa, Botswana, and Brasil
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV seropositive women 18 years of age and older Consent signed per local IRB
             requirement

        Exclusion Criteria:

          -  Can not give blood
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia S Firnhaber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical HIV Research Unit University of Witwatersrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shahin Lockman</name>
      <address>
        <city>Habarone</city>
        <country>Botswana</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fundacao Oswaldo Cruz</name>
      <address>
        <city>Rio De Janeiro</city>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Witwatersrand/Helen Joseph Hospital</name>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Botswana</country>
    <country>Brazil</country>
    <country>South Africa</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2009</study_first_submitted>
  <study_first_submitted_qc>February 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2009</study_first_posted>
  <last_update_submitted>November 6, 2012</last_update_submitted>
  <last_update_submitted_qc>November 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Witwatersrand, South Africa</investigator_affiliation>
    <investigator_full_name>Cynthia S Firnhaber</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>HPV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

